Lexeo Therapeutics LXEO
NASDAQ LXEO
$2.89 -0.11 (-3.67%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) EBIT Margin (2022)

Updated

Lexeo Therapeutics (LXEO) reported EBIT Margin of -9252.14% for FY2022.

Analysis

Lexeo Therapeutics (LXEO) EBIT Margin (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 24.35%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 37.86%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 20.57%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 28.37%
10 Lexeo Therapeutics 248.75 Mn -411.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -3,292.28%
API Access

Lexeo Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=LXEO&period=max&api_key=YOUR_API_KEY